Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
about
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implications.Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission.Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response.Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.
P2860
Q33915990-36DF076C-5129-4D29-847E-9E68B43C86FAQ36036328-B264FFAB-D8B8-498F-B28B-91105C9EB9ADQ37161949-8DFBB9FF-C376-466C-A7C1-1EAC51894E38Q37429911-9007929E-6F2F-4550-85BE-46B0547AACA1Q38133244-3B3D9EF3-9AC7-455B-BF27-D262CBFFBFD8Q38953608-6D1F0950-9B34-4B07-AA02-0B5F58E6EDBBQ39212390-1762A3BB-8CFA-4D86-B488-D227DD13A48CQ39632454-B6CAB6A2-0BAF-4CDE-9BB2-0612BC710DA6Q41688221-A9AC9D88-97BF-48F1-8724-5DBB0F0061ECQ42586040-D12A7458-5C0F-4DFA-B49B-D19E57A20B72Q47563781-FCE05A9E-F7E7-4658-9851-E0A816BC724CQ48254230-8BCA63D0-3895-4C69-8A4D-A1FBD055AC28
P2860
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clofarabine combined with busu ...... tic stem cell transplantation.
@ast
Clofarabine combined with busu ...... tic stem cell transplantation.
@en
type
label
Clofarabine combined with busu ...... tic stem cell transplantation.
@ast
Clofarabine combined with busu ...... tic stem cell transplantation.
@en
prefLabel
Clofarabine combined with busu ...... tic stem cell transplantation.
@ast
Clofarabine combined with busu ...... tic stem cell transplantation.
@en
P2093
P2860
P1476
Clofarabine combined with busu ...... tic stem cell transplantation.
@en
P2093
Borje S Andersson
E J Shpall
Issa Khouri
M Qazilbash
Partow Kebriaei
P2860
P304
P356
10.1016/J.BBMT.2012.06.010
P577
2012-06-29T00:00:00Z